Your browser doesn't support javascript.
loading
Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice.
Conde, Eva; Bertrand, Romain; Balbino, Bianca; Bonnefoy, Jonathan; Stackowicz, Julien; Caillot, Noémie; Colaone, Fabien; Hamdi, Samir; Houmadi, Raïssa; Loste, Alexia; Kamphuis, Jasper B J; Huetz, François; Guilleminault, Laurent; Gaudenzio, Nicolas; Mougel, Aurélie; Hardy, David; Snouwaert, John N; Koller, Beverly H; Serra, Vincent; Bruhns, Pierre; Grouard-Vogel, Géraldine; Reber, Laurent L.
Afiliação
  • Conde E; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.
  • Bertrand R; Sorbonne University, ED394, Paris, France.
  • Balbino B; Neovacs SA, Paris, France.
  • Bonnefoy J; Neovacs SA, Paris, France.
  • Stackowicz J; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.
  • Caillot N; Sorbonne University, ED394, Paris, France.
  • Colaone F; Neovacs SA, Paris, France.
  • Hamdi S; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.
  • Houmadi R; Sorbonne University, ED394, Paris, France.
  • Loste A; Neovacs SA, Paris, France.
  • Kamphuis JBJ; Neovacs SA, Paris, France.
  • Huetz F; Neovacs SA, Paris, France.
  • Guilleminault L; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.
  • Gaudenzio N; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.
  • Mougel A; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.
  • Hardy D; Unit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR 1222 INSERM, Paris, France.
  • Snouwaert JN; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.
  • Koller BH; Department of respiratory medicine, Toulouse University Hospital, Faculty of Medicine, Toulouse, France.
  • Serra V; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.
  • Bruhns P; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France.
  • Grouard-Vogel G; Institut Pasteur, Experimental Neuropathology Unit, Paris, France.
  • Reber LL; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Nat Commun ; 12(1): 2574, 2021 05 11.
Article em En | MEDLINE | ID: mdl-33976140
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Interleucina-4 / Vacinação / Interleucina-13 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Interleucina-4 / Vacinação / Interleucina-13 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França